Why did TMD.TO stock spike pre-market?

The spike likely reflects heavy retail interest, short-covering and thin liquidity rather than confirmed corporate news. Volume hit **117,220.00** shares versus an average of **45,936.00**, creating rapid price movement.

What are the main valuation metrics for Titan Medical?

Titan lists EPS **-1.73** and market cap **CAD 128,295,000.00**. Price averages are **CAD 0.07** (50-day) and **CAD 0.07** (200-day). These metrics show a speculative, development-stage valuation.

How does Meyka AI view TMD.TO stock?

Meyka AI rates TMD.TO **68.65/100** (Grade B, Suggestion: HOLD). The grade factors in benchmark and sector comparison, growth metrics and analyst inputs. This is informational, not financial advice.

What should traders watch after the pre-market surge?

Watch order-book depth, follow-through volume in the first two trading hours, any regulatory filings or press releases, and whether price holds above strategic levels like **CAD 0.20** or the day high.

CA Stocks

TMD.TO up 2149% pre-market: Titan Medical (TSX) 09 Feb 2026 monitor volume and catalysts

ByHuzaifa Zahoor February 9, 2026

TMD.TO stock opened pre-market at CAD 1.125, a 2149.00% rise from the prior close of CAD 0.05 on heavy volume. We’re watching whether this move is a short squeeze, a news-driven re-rating, or a temporary liquidity event. Average daily volume is 45,936.00 shares vs today’s 117,220.00 shares, so trading intensity is the key immediate signal for traders and longer-term investors.